APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference45 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015
2. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey;Rosenthal;Cancer,2015
3. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma;Garnelo;Gut,2017
4. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis;Gooden;Br. J. Cancer,2011
5. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome;Galon;Science,2006
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer and immune response: The role of PD-1/PD-L1 checkpoint in laryngeal carcinoma. Preliminary results;European Archives of Oto-Rhino-Laryngology;2024-07-28
2. Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women;Breast Cancer Research and Treatment;2024-07-05
3. Advances in tumor immune microenvironment of head and neck squamous cell carcinoma: A review of literature;Medicine;2024-03-01
4. The APE1/REF-1 and the hallmarks of cancer;Molecular Biology Reports;2024-01-02
5. The construction and validation of ECM-related prognosis model in laryngeal squamous cell carcinoma;Heliyon;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3